Laila Hassan M El-Shazly1, Amal Ahmad El-Gohary2, Ghada Ghanem El-Hossary3. 1. Department of Ophthalmology, Memorial Institute of Ophthalmology, 3-Al-Ahram Street, Giza, Cairo 12511, Egypt. 2. Department of Physiology, Research Institute of Ophthalmology, 2-Al-Ahram Street, Giza, Cairo 12511, Egypt. 3. Department of Pharmacology, Research Institute of Ophthalmology, 2-Al-Ahram Street, Giza, Cairo 12511, Egypt.
Abstract
AIM: To evaluate the retinal safety of various doses of intravitreal triamcinolone acetonide (TA) in rabbits. METHODS: Thirty New Zealand albino rabbits were divided into five groups (six animals each). In group 1 (control group), each animal received a single intravitreal injection of 0.1mL phosphate buffered saline. In groups 2, 3, 4 and 5, each rabbit received a single intravitreal injection of 4, 8, 16 and 32mg of TA, respectively. Each dose was contained in 0.1mL phosphate buffered saline. Clinical ocular examinations were performed before the injection and on the 1st, 3rd, 10th and 17th post-injection days. A standard dark adapted electroretinogram (ERG) was obtained before injection and on the 3rd, 10th and 17th post-injection days. After 17d, animals were sacrificed and their eyes prepared for pathological examination. RESULTS: By monitoring ERG as a functional index for the retina, intravitreal injection of 4mg TA showed no significant ERG changes. At doses of 8, 16 and 32, hyper-abnormal responses in a- and b- waves of ERG were detected on the 3rd post-injection day. These changes gradually returned back to normal limits after 17d. Histopathological examination of the retina of all animals showed no pathological changes. CONCLUSION: High doses of intravitreal TA seemed to have enhancing effects on the retinal function with gradual return to normal limits with no pathological changes detected in examined eyes.
AIM: To evaluate the retinal safety of various doses of intravitreal triamcinolone acetonide (TA) in rabbits. METHODS: Thirty New Zealand albino rabbits were divided into five groups (six animals each). In group 1 (control group), each animal received a single intravitreal injection of 0.1mL phosphate buffered saline. In groups 2, 3, 4 and 5, each rabbit received a single intravitreal injection of 4, 8, 16 and 32mg of TA, respectively. Each dose was contained in 0.1mL phosphate buffered saline. Clinical ocular examinations were performed before the injection and on the 1st, 3rd, 10th and 17th post-injection days. A standard dark adapted electroretinogram (ERG) was obtained before injection and on the 3rd, 10th and 17th post-injection days. After 17d, animals were sacrificed and their eyes prepared for pathological examination. RESULTS: By monitoring ERG as a functional index for the retina, intravitreal injection of 4mg TA showed no significant ERG changes. At doses of 8, 16 and 32, hyper-abnormal responses in a- and b- waves of ERG were detected on the 3rd post-injection day. These changes gradually returned back to normal limits after 17d. Histopathological examination of the retina of all animals showed no pathological changes. CONCLUSION: High doses of intravitreal TA seemed to have enhancing effects on the retinal function with gradual return to normal limits with no pathological changes detected in examined eyes.
Authors: Osman Cekiç; Stanley Chang; Joseph J Tseng; Gaetano R Barile; Harold Weissman; Lucian V Del Priore; William M Schiff; Michael Weiss; James M Klancnik Journal: Retina Date: 2005 Oct-Nov Impact factor: 4.256
Authors: Francesco Semeraro; Francesco Morescalchi; Sarah Duse; Elena Gambicorti; Andrea Russo; Ciro Costagliola Journal: J Ophthalmol Date: 2015-09-03 Impact factor: 1.909